在Saccharomyces cerevisiae中的重组猪表皮生长因子的分泌表达和发酵优化
Jie Liu1, Wenjun Xu2, Bingbing Xia2
1College of Biotechnology and Pharmaceutical Engineering, West Anhui University, Lu'an, Anhui, 237012, China.
Protein expression and purification
|October 9, 2025
概括
我们开发了一种酵母菌株,用于生产用于猪料的重组猪皮表皮生长因子 (PoEGF). 这种具有成本效益的方法可以在不经过净化的情况下产生生物活性PoEGF,从而提供了抗生素替代品.
科学领域:
- 生物技术是生物技术.
- 动物科学动物科学
- 分子生物学分子生物学
背景情况:
- 猪皮表皮生长因子 (PoEGF) 支持小猪肠道健康和免疫力.
- 目前的重组PoEGF (rPoEGF) 生产是昂贵的,需要大量的净化.
- 在生猪生产中,rPoEGF为料抗生素提供了潜在的替代品.
研究的目的:
- 开发一种具有成本效益和可扩展的方法来生产生物活性rPoEGF.
- 为了设计Saccharomyces cerevisiae以有效分泌rPoEGF.
- 为了优化发酵条件的高产 rPoEGF生产.
主要方法:
- 构建了一个复合酵母菌株 (Saccharomyces cerevisiae INVSc1) 与一个α-因子信号-PoEGF-6×他的表达盒.
- 通过SDS-PAGE和西方 blot.确认蛋白质表达.
- 在4L生物反应器中优化了两阶段发酵策略 (食批量生长,在25°C,pH为5.0,DO为30%的温度下引起银河糖的表达).
- 使用BALB/c 3T3纤维细胞增殖试验验验证的生物活性.
主要成果:
- 达到了最大的10963个单位/毫升的线粒生成活性.
- 达到高细胞密度培养 (OD600 ≈ 71.5).
- 获得了30.2 mg/L的最终分泌蛋白产量.
- 证明了培养上游物作为料添加剂的直接应用,无需净化.
结论:
- 开发了一种实用,可扩展和具有成本效益的方法,用于使用工程酵母生产生物活性rPoEGF.
- 含有rPoEGF的酵母培养物可以直接用作功能性料添加剂.
- 这种方法支持rPoEGF作为安全的,无抗生素的生长促进剂在猪生产中的应用.
相关概念视频
Bioreactor Controls-III
67
Strain improvement is a foundational strategy in industrial microbiology aimed at maximizing microbial productivity, particularly because natural isolates typically yield commercially valuable products in very low concentrations. Although optimizing the culture medium and environmental conditions can improve yields, these adjustments are inherently limited by the organism’s genetic potential. As a result, the focus shifts toward genetic modifications to enhance biosynthetic capacity. The...
67
Upstream Processing
97
Upstream processing represents a critical phase in biomanufacturing, wherein biological systems such as microorganisms, mammalian cells, or insect cells are cultivated to produce therapeutic proteins, vaccines, enzymes, or other biologically derived products. This phase encompasses all steps from the selection and genetic manipulation of the production organism to the cultivation of cells in bioreactors under tightly controlled environmental conditions.Host Selection and Genetic OptimizationThe...
97
Production of Pharmaceuticals
94
Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under...
94


